An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center

Shawn M Varney1, Sarah Watkins2, Haylea Stuteville3

  • 1University of Texas Health San Antonio - San Antonio, TX, USA.

Hospital Pharmacy
|June 26, 2024
PubMed

Insights

Pediatric metformin ingestions under 85 mg/kg generally result in uneventful medical outcomes. This study analyzed 669 cases in children 5 years and younger, finding no major effects or deaths.

Area of Science:

  • Pediatric Toxicology
  • Clinical Pharmacology
  • Emergency Medicine

Background:

  • Poison control centers establish triage guidelines for pediatric metformin ingestions.
  • The established network guideline is 1700 mg, or 85 mg/kg.

Purpose of the Study:

  • To investigate the dose, clinical course, and outcomes of inadvertent metformin ingestions in young children.
  • To analyze data from a statewide poison center network for patients 5 years old and younger.

Main Methods:

  • Retrospective review of a poison center database from 2011 to 2021.
  • Inclusion criteria: metformin ingestions in patients 5 years and younger.
  • Descriptive statistics were used to analyze variables including age, weight, dose, symptoms, and outcomes.

Main Results:

  • A total of 669 cases were analyzed; most ingestions (98.5%) were unintentional.
  • Median recorded dose was 500 mg (42.4 mg/kg) in 15.4% of cases with available data.
  • Most patients (66.5%) were managed non-healthcare facilities; among those seeking care, 82.8% were discharged from the emergency department, with no major effects or deaths reported.

Conclusions:

  • Pediatric metformin ingestions, particularly those under 85 mg/kg, are associated with predominantly benign medical outcomes.
  • Limited recorded dosage information in pediatric ingestions presents a challenge for precise risk assessment.
  • The findings support the current triage guidelines for pediatric metformin exposures.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
817
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K